A Multicenter, Randomized, Open-Label, Phase 3 Trial Comparing LOXO-292 to Platinum-Based and Pemetrexed Therapy with or without Pembrolizumab as Initial Treatment of Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
- Parakh, Sagun (Chief Investigator (CI))
- Alamgeer, Muhammad (Primary Chief Investigator (PCI))
Project: Research